Abellan R, Ventura R, Pichini S, Palmi I, Bellver M, Olive R, Pacifici R, Pascual J A, Zuccaro P, Segura J
Pharmacology Research Unit, Institut Municipal d'Investigació Mèdica, Barcelona, Spain.
Int J Sports Med. 2007 Jan;28(1):9-15. doi: 10.1055/s-2006-924029. Epub 2006 Jun 26.
Erythropoietin (EPO) and soluble transferrin receptor (sTfR) in serum have been proposed as indirect biomarkers for the detection of recombinant human EPO (rhEPO) misuse in sport. The purpose of the present study was to investigate the influence of different levels of physical fitness, sport, different training workload during the sport season, and endurance exercise in the concentrations of these serum biomarkers for their application into mathematical models to indirectly detect rhEPO misuse. Serum EPO and sTfR concentrations were measured in 96 elite athletes of various sports along the sport season, in 21 recreational athletes at baseline (non exercising) conditions and in 129 other recreational athletes before and after long-distance races (10 and 21 km). In elite athletes, hemoglobin concentrations and percentage of reticulocytes were also measured, and indirect detection models applied. In recreational athletes, for EPO and sTfR, significant differences were only observed after the 21-km race. In baseline conditions, no differences were observed between recreational and elite athletes for EPO and sTfR. In elite athletes, individual EPO and sTfR concentrations slightly changed over the sport season, with coefficients of variation (CV) of 26.1 % and 9.0 %, respectively. Hemoglobin and reticulocytes were influenced by sport, but their individual variation over the sport season was not physiologically relevant (CV of 3.7 % and 21.3 %, respectively). When applying mathematical models for detection of rhEPO administration, only one elite athlete obtained an individual model score above the established thresholds. Physical fitness, sport and different training workload during the sport season had no substantial effect on serum EPO and sTfR concentrations, except in recreational athletes after a 21-km race. Variations observed in mathematical models to detect EPO administration were mainly due to fluctuation in hemoglobin concentrations, commonly observed in elite athletes.
血清中的促红细胞生成素(EPO)和可溶性转铁蛋白受体(sTfR)已被提议作为检测体育赛事中重组人促红细胞生成素(rhEPO)滥用情况的间接生物标志物。本研究的目的是调查不同体能水平、运动项目、运动赛季期间不同训练负荷以及耐力运动对这些血清生物标志物浓度的影响,以便将其应用于数学模型中,间接检测rhEPO的滥用情况。在整个运动赛季对96名不同运动项目的精英运动员、21名处于基线(不运动)状态的业余运动员以及129名其他业余运动员在长跑(10公里和21公里)前后的血清EPO和sTfR浓度进行了测量。在精英运动员中,还测量了血红蛋白浓度和网织红细胞百分比,并应用了间接检测模型。在业余运动员中,仅在21公里比赛后观察到EPO和sTfR有显著差异。在基线状态下,业余运动员和精英运动员的EPO和sTfR没有差异。在精英运动员中,个体EPO和sTfR浓度在运动赛季中略有变化,变异系数(CV)分别为26.1%和9.0%。血红蛋白和网织红细胞受运动影响,但它们在运动赛季中的个体变化在生理上并不相关(CV分别为3.7%和21.3%)。当应用数学模型检测rhEPO的使用情况时,只有一名精英运动员的个体模型得分超过既定阈值。体能、运动项目和运动赛季期间不同的训练负荷对血清EPO和sTfR浓度没有实质性影响,21公里比赛后的业余运动员除外。在检测EPO使用情况的数学模型中观察到的变化主要是由于精英运动员中常见的血红蛋白浓度波动。